Esmo.org - SEO Checker

Sign up for free! PDF Export
Overview of the SEO Check
Meta information
100% 
Page quality
47% 
Page structure
58% 
Link structure
11% 
Server
100% 
External factors
100% 
SEO Score
Response time
0.10 s
File size
340.00 kB
Words
4178
Media files
26
Number of links
448 internal / 36 external

Task list of SEO Improvements

Meta specifications

Title
(Critically important)
European Society for Medical Oncology
The length of the page title is perfect. (355 pixels out of 580 max pixel length)
There are no duplicate words in the title
Meta description
(Critically important)
ESMO is Europe’s leading medical oncology society, providing a professional network for its members and working with national societies across Europe.
The length of the meta description is perfect. (944 pixels out of 1000 max pixel length)
Crawlability
(Critically important)
There are no problems in accessing the website.
Canonical URL
(Important)
https://www.esmo.org/
There is a valid canonical link specified.
Language
(Somewhat important)
Language detected in text: en
Language defined in HTML: en-gb
Server location: United States of America
The following language is defined by HTML: en-gb
Alternate/Hreflang Links
(Somewhat important)
There are no alternate links specified on this page.
Other meta tags
(Somewhat important)
There is no rel next meta tag on this page.
There is no rel prev meta tag on this page.
Domain
(Somewhat important)
The domain is no subdomain.
The domain length is good.
The domain does not contain non-latin characters.
Page URL
(Somewhat important)
No parameters were found in the URL.
No session ID was found in the URL.
The URL does not have too many subdirectories.
Charset encoding
(Somewhat important)
The charset encoding (UTF-8) is set correctly.
Doctype
(Nice to have)
The doctype HTML 5 is set correctly.
The doctype is placed at first in the HTML code.
Favicon
(Nice to have)
The favicon is linked correctly.

Meta tags

NameValue
copyrightESMO
authorESMO
keywordsmedical oncology,oncologists,oncology societies,oncology conferences,europe
descriptionESMO is Europe’s leading medical oncology society, providing a professional network for its members and working with national societies across Europe.
generatoreZ Platform powered by Netgen
viewportwidth=device-width, initial-scale=1.0, maximum-scale=1
norton-safeweb-site-verificationn2ygvjh9mxjj82z9-mte778jumy0erkkd7zxsvx7ps8mpqx4avfdqnwqcw9dvfcmta5hjtjeya4vwcgxzq52gv3kdxnunzhimdkkks2zl39icco8x7d45ihmrkklqfc4
facebook-domain-verification3eeragwmlcd46ur5vkwb776r9jtxte
msvalidate.01BDC2955EF05146A4D0BC9BE3E6DF32BD
langen-gb
og:typewebsite
og:titleESMO
og:descriptionESMO
og:imagehttps://www.esmo.org/bundles/app/images/esmo_opengraph.png
charsetutf-8

Test up to 1.000 webpages of esmo.org with our free plan!

Try For Free
No trial. It's just free!

Page quality

Content
(Critically important)
The content of this page is too large (4178 words). Maybe the content could be divided into several pages.
There are 6 text duplicates on this page:
  • Duplicate 1: It is intended for the treatment of adult patients with relapsed or re...
  • Duplicate 2: In the MARIPOSA study, a significant improvement in progression-free s...
  • Duplicate 3: New indication concerns a combination with durvalumab for the maintena...
The average number of words per sentence of 71.88 words is high.
26.3% of the text are stop words.
Keywords used in the page title are also used in the page content. That's good!
Words from the H1 heading are used in the page content.
The page contains a listing, which indicates a good text layout.
46 paragraphs were found on this page.
No placeholders texts or images were found.
Frames
(Critically important)
This page does not use a frameset.
Mobile optimization
(Somewhat important)
No Apple touch icon is specified.
A viewport "width=device-width, initial-scale=1.0, maximum-scale=1" is provided.
Bold and strong tags
(Somewhat important)
Some tags are too long. With 118 characters this one is longer than 70 characters:
"oops, you're using an old version of your browser so some of the features on this page may not be disp..."
Image SEO
(Somewhat important)
Alt text (alternative text) is correctly used on all found images.
Social Networks
(Nice to have)
There are only a few social sharing widgets on the page. Make your website popular in social networks with social sharing widgets.
Additional markup
(Nice to have)
No additional page markup was found.
HTTPS
(Somewhat important)
This website uses HTTPS to protect privacy and integrity of the exchanged data.
All included files are also transferred via HTTPS.

Media list

URLAlt attributeTitle
...age/30169140e251db563e46719de7ec91e4.svgESMO
...inoma-esmo-euracan-1000x250-july_i30.jpgESMO-Webinar-Series-Nasopharyngeal-Carcinoma-ESMO-EURACAN-1000x250-July
...tatic-non-small-cell-lung-cancer_i30.jpgESMO-Clinical-Practice-Guidelines-1000x250-Oncogene-Addicted-Metastatic-Non-Small-Cell-Lung-Cancer
...ceptorship-lung-cancer-1000x1000_i30.jpgESMO-Preceptorship-Lung-Cancer-1000x1000
...torship-gastric-cancer-1000x1000_i30.jpgESMO-Preceptorship-Gastric-Cancer-1000x1000
...795-3-eng-GB/esmo-mcbs-1000x1000_i30.jpgESMO-MCBS 1000x1000
...ients-with-the-best-care-options_i30.jpgProvide your patients with the best care options.
...es/4397014-1-eng-GB/esmo-courses_i30.jpgESMO Courses
...-1-eng-GB/esmo-oncology-journals_i30.jpgESMO Oncology Journals
...ns/4396970-1-eng-GB/publications_i30.jpgPublications
...t-course-valencia-2024-1000x1000_i30.jpgESMO-Medical-Student-Course-Valencia-2024-1000x1000
...ptorship-breast-cancer-1000x1000_i30.jpgESMO-Preceptorship-Breast-Cancer-1000x1000
...o-academy-meeting-2024-1000x1000_i30.jpgESMO-Academy-Meeting-2024-1000x1000
...ent-course-naples-2024-1000x1000_i30.jpgESMO-Medical-Student-Course-Naples-2024-1000x1000
...-courses-breast-cancer-1000x1000_i30.jpgESMO-Advanced-Courses-Breast-Cancer-1000x1000
...-GB/esmo-congress-2024-1000x1000_i30.jpgESMO-Congress-2024-1000x1000
...ip-ovarian-cancer-2024-1000x1000_i30.jpgESMO-Preceptorship-Ovarian-Cancer-2024-1000x1000
...torship-gastric-cancer-1000x1000_i30.jpgESMO-Preceptorship-Gastric-Cancer-1000x1000
...lecular-cancer-biology-1000x1000_i30.jpgESMO-Preceptorship-Molecular Cancer Biology-1000x1000
...o-advanced-courses-adc-1000x1000_i30.jpgESMO-Advanced-Courses-ADC-1000x1000
...o-advanced-courses-adc-1000x1000_i30.jpgESMO-Advanced-Courses-ADC-1000x1000
...o-advanced-courses-adc-1000x1000_i30.jpgESMO-Advanced-Courses-ADC-1000x1000
Video URLWidthHeight
https://www.youtube.com/embed/ybpRSarS2TY770433
https://www.youtube.com/embed/iPoTPdElxtU770433
https://www.youtube.com/embed/d1ZiZbh8mOk770433

Page structure

H1 heading
(Critically important)
European Society For Medical Oncology
The H1 heading is perfect.
Headings
(Important)
Some headings occur twice on the page.
There are 100 headings on the page. The amount of headings should be in a more proper relation to the amount of text.

Heading structure

Heading levelContent
H1 European Society For Medical Oncology
H2 ESMO Immuno-Oncology Congress 2024
H2 Nasopharyngeal Carcinoma Webinar
H2 ESMO Oncogene-Addicted mNSCLC Living Guideline
H2 ESMO Asia 2024
H2 Molecular Analysis for Precision Oncology Congress 2024
H2 ESMO Preceptorship on Lung Cancer, 15-16 November 2024, Paris, France
H2 ESMO Preceptorship Course on Gastric Cancer, 4-5 December 2024, Singapore
H2 ESMO-MCBS
H2 July ESMO Virtual Plenary
H2 Latest News
H2 Development of T-Cell Lymphoma After Chimeric Antigen Receptor T-Cell Therapy
H2 EMA Recommends Granting a Conditional Marketing Authorisation for Odronextamab
H2 Entrectinib Is Effective and Well Tolerated in Patients with Treatment-Naïve ROS1-positive Advanced/Metastatic NSCLC
H2 FDA Approves Durvalumab with Chemotherapy for Mismatch Repair Deficient Primary Advanced or Recurrent Endometrial Cancer
H2 First-line avimantamab plus lazertinib shows efficacy in patients with high-risk EGFR-mutant advanced NSCLC
H2 One Year of Adjuvant T-DM1 Leads to Outstanding Long-Term Outcomes Among Patients with Stage I HER2-positive Breast Cancer
H2 Patient Guide in Bladder Cancer Now Available Also in Greek
H2 EMA Recommends Extension of Therapeutic Indications for Olaparib to Patients with Endometrial Cancer
H2 PET-2-Guided BrECADD Better Tolerated and More Effective than eBEACOPP in Patients with Newly Diagnosed, Advanced-Stage cHL
H2 Development of T-Cell Lymphoma After Chimeric Antigen Receptor T-Cell Therapy Duplicate text
H2 EMA Recommends Granting a Conditional Marketing Authorisation for Odronextamab Duplicate text
H2 Entrectinib Is Effective and Well Tolerated in Patients with Treatment-Naïve ROS1-positive Advanced/Metastatic NSCLC Duplicate text
H2 FDA Approves Durvalumab with Chemotherapy for Mismatch Repair Deficient Primary Advanced or Recurrent Endometrial Cancer Duplicate text
H2 One Year of Adjuvant T-DM1 Leads to Outstanding Long-Term Outcomes Among Patients with Stage I HER2-positive Breast Cancer Duplicate text
H2 EMA Recommends Extension of Therapeutic Indications for Olaparib to Patients with Endometrial Cancer Duplicate text
H2 PET-2-Guided BrECADD Better Tolerated and More Effective than eBEACOPP in Patients with Newly Diagnosed, Advanced-Stage cHL Duplicate text
H2 FDA Grants Accelerated Approval to Adagrasib with Cetuximab for KRAS G12C-mutated Advanced Colorectal Cancer
H2 Second- or Third-Line Treatment with Tisotumab Vedotin Results in Greater Efficacy than Chemotherapy in Patients with Recurrent Cervical Cancer
H2 Prevention and Early Detection of Gastrointestinal Cancers Take on New Importance Amidst a Younger Population
H2 Cross-Border Network of European Specialists Provides New Treatment Options For Women with Complex Rare Gynaecological Cancers
H2 ESMO Gastrointestinal Cancers Congress 2024 Munich, Germany, 26-29 June
H2 ESMO Gynaecological Cancers Congress 2024, 20-22 June, Florence, Italy
H2 World No Tobacco Day 2024: European Societies call for an EU Endgame on Tobacco
H2 Assisted Reproduction Treatments are Safe in Young Breast Cancer Survivors with High-risk Genes
H2 ESMO Breast Cancer 2024, 15-17 May, Berlin, Germany
H2 European Lung Cancer Congress 2024, 20-23 March, Prague, Czech Republic
H2 ESMO Sarcoma and Rare Cancers Congress 2024, 14-16 March, Lugano, Switzerland
H2 ESMO Calls for Urgent Action at Both EU and National Levels to Safeguard the Future of Oncological Research in Europe
H2 ESMO Journals Have Maintained Strong Impact Factors
H2 New ESMO President 2027-2028 Elected
H2 Three Prominent ESMO Officers Shine in News Pages for Their Accomplishments in Cancer Research
H2 Medical Oncologists Incredulous at the Commission’s Latest Backtracking on the Evaluation of the EU Tobacco Products Directive
H2 2024 ESMO Breast Cancer Award Recipient Announced
H2 2024 Heine H. Hansen Award Recipient Announced
H2 Nomination Process for the 2024 ESMO Society Awards Now Open 
H2 ESMO Committees and Working Groups: New Chair Appointments
H2 First-line avimantamab plus lazertinib shows efficacy in patients with high-risk EGFR-mutant advanced NSCLC Duplicate text
H2 Eftilagimod alpha plus pembrolizumab shows promise in HNSCC with negative PD-1 expression
H2 How to interpret genomic testing results? ESMO recommendations to make reports easy to read
H2 Oncologists do not feel well-prepared to address the health needs of LGBTQ cancer patients
H2 Doublet immunotherapy consolidates its role in hepatocellular carcinoma
H2 Ten years of improvement in the treatment of liver cancer
H2 Growing evidence supports the use of ctDNA as a biomarker in colon cancer
H2 Harnessing the power of the gut microbiome in colorectal cancer
H2 Liver transplantation plus chemotherapy prolongs survival in patients with definitively unresectable colorectal liver metastases
H2 Education
H2 Provide your patients with the best care options.
H2 ESMO Courses
H2 ESMO Oncology Journals
H2 Publications
H2 Next Meetings
H2 ESMO Course in Medical Oncology for Medical Students Valencia 2024
H2 ESMO Preceptorship on Breast Cancer 2024: Munich
H2 ESMO Academy 2024
H2 ESMO Course in Medical Oncology for Medical Students Naples 2024
H2 ESMO Advanced Course on Role of CDK4/6 Inhibitors in Hormone Receptor Positive HER2 Negative in Breast Cancer 2024: Jeddah
H2 ESMO Congress 2024
H2 ESMO Preceptorship on Ovarian Cancer 2024: Lisbon
H2 ESMO Preceptorship on Gastric Cancer 2024: Lisbon
H2 ESMO Preceptorship on Practising Oncology: Dealing with Special Strategies, Patient Populations and Toxicities 2024: Lugano
H2 ESMO Advanced Course on ADC Development, Therapeutic Applications and Research: Breast, Gynaecological and GI Cancers 2024: Zurich
H2 ESMO Advanced Course on ADC Development, Therapeutic Applications and Research: Thoracic and GU Cancers 2024: Singapore
H2 ESMO Advanced Course on ADC Development, Therapeutic Applications and Research: Breast, Gynaecological and GI Cancers 2024: Singapore
H2 Video Gallery
H2 ESMO Immuno-Oncology 2024: Congress Experts in the field invite you to share your research.
H2 ESMO Women for Oncology Forum 2023: 10 years of ESMO W4O advocating for gender equity
H2 ESMO Virtual Mentorship Programme
H2 ESMO/ASCO Global Curriculum in Medical Oncology: Insights on the 2023 Edition
H2 ESMO/ASCO Global Curriculum in Medical Oncology: Insights on the 2023 Edition Duplicate text
H2 #ESMO24: F. André, R. Dent, M. Garassino, M. Van der Heijden & M. Lambertini invite you to attend
H2 Precision Medicine in Prostate Cancer
H2 ESMO Asia Congress 2024: multidisciplinary oncology in the Asian region
H2 Unlock your future: Why Young Oncologists should attend MAP 2024
H2 Recommendations for the use of NGS in patients with metastatic cancer
H2 Precision oncology experts on why you should submit your abstract for MAP 2024
H2 Why you should submit your abstract for MAP 2024
H2 Career Development
H2 Improve your career path
H2 Are you looking for a fellowship not offered by ESMO or would like to post a fellowship?
H2 ESMO Examination
H2 Thinking of applying for an ESMO Oncology Fellowship?
H2 Become a Member
H3 Membership
H4 172
H4 35k +
H4 40+
H5 Legal
H5 Useful links
H5 Subscribe to ESMO newsletters
There are too many internal links (448) on this page.
Some internal link anchor texts are too long.
Some internal links have dynamic parameters. All internal URLs, which are not marked as nofollow, should not contain dynamic parameters.
Some anchor texts are used more than once.
There are 1 links with a trivial anchor text.
There are too many external links (36) on this page.

Found links on this page

LinkAttributesAnchor text
https://www.google.com/chrome/New window External Subdomain Google Chrome 24+
https://www.mozilla.org/en-US/...New window External Subdomain Mozilla Firefox 20+
https://www.microsoft.com/en-u...New window External Subdomain Internet Explorer 11
https://www.opera.com/downloadNew window External Subdomain Opera 15–18
https://www.apple.com/safari/New window External Subdomain Apple Safari 7
https://www.seamonkey-project....New window External Subdomain SeaMonkey 2.15-2.23
https://www.esmo.org/Subdomain ESMO
/meeting-calendarSubdomain Meeting Calendar
https://oncologypro.esmo.org/External Subdomain OncologyPRO
/membership/join-esmoSubdomain Become a member
https://www.esmo.org/saml/loginLogin
https://www.esmo.org/Subdomain Text duplicate IMG-ALT ESMO
A-TITLE ESMO
/membership/member-benefitsSubdomain Benefits of an ESMO Membership
https://www.esmo.org/about-esmoSubdomain Who we are
/about-esmo/how-we-workSubdomain How we work
/about-esmo/esmo-valuesSubdomain Our values
https://www.esmo.org/Subdomain Text duplicate ESMO
/meeting-calendarSubdomain Text duplicate Meeting Calendar
https://oncologypro.esmo.org/External Subdomain Text duplicate OncologyPRO
https://www.esmo.org/about-esmoSubdomain About ESMO
A-TITLE About ESMO
/about-esmo/esmo-vision-2025Subdomain ESMO Vision 2025
/about-esmo/esmo-vision-2025/o...Subdomain One Oncology Community
/about-esmo/esmo-vision-2025/e...Subdomain Education for Life
/about-esmo/esmo-vision-2025/a...Subdomain Accessible Cancer Care
/about-esmo/esmo-missionSubdomain ESMO Mission
/about-esmo/esmo-valuesSubdomain ESMO Values
/about-esmo/awardsSubdomain Awards
/about-esmo/awards/esmo-award-...Subdomain ESMO Award Nominations
/about-esmo/awards/fellow-of-e...Subdomain Fellow of ESMO (FESMO)
/about-esmo/awards/fellow-of-e...Subdomain FESMO 2022
/about-esmo/awards/esmo-awardSubdomain ESMO Award
/about-esmo/awards/esmo-award-...Subdomain ESMO Award for Translational Research
/about-esmo/awards/esmo-women-...Subdomain ESMO Women for Oncology Award
/about-esmo/awards/esmo-lifeti...Subdomain ESMO Lifetime Achievement Award
/about-esmo/awards/esmo-breast...Subdomain ESMO Breast Cancer Award
/about-esmo/awards/heine-h.-ha...Subdomain Heine H. Hansen Award
/about-esmo/awards/esmo-award-...Subdomain ESMO Award for Immuno-Oncology
/about-esmo/awards/tat-honorar...Subdomain TAT Honorary Award
/about-esmo/organisational-str...Subdomain Organisational Structure
/about-esmo/organisational-str...Subdomain ESMO Council
/about-esmo/organisational-str...Subdomain Executive Board
/about-esmo/organisational-str...Subdomain Annals of Oncology Editorial Board
/about-esmo/organisational-str...Subdomain Audit Committee
/about-esmo/organisational-str...Subdomain Cancer Medicines Committee
/about-esmo/organisational-str...Subdomain Compliance Committee
/about-esmo/organisational-str...Subdomain Educational Committee
/about-esmo/organisational-str...Subdomain Adolescents and Young Adults Working Group
/about-esmo/organisational-str...Subdomain Designated Centres Working Group
/about-esmo/organisational-str...Subdomain Educational Publications Working Group
/about-esmo/organisational-str...Subdomain ESMO Faculty
/about-esmo/organisational-str...Subdomain ESMO SIOG Cancer in the Elderly Working Group
/about-esmo/organisational-str...Subdomain Examination & Accreditation Working Group
/about-esmo/organisational-str...Subdomain OncologyPRO Working Group
/about-esmo/organisational-str...Subdomain Practising Oncologists Working Group
/about-esmo/organisational-str...Subdomain Real World Data and Digital Health Working Group
/about-esmo/organisational-str...Subdomain Translational Research and Precision Medicine Working Group
/about-esmo/organisational-str...Subdomain Text duplicate ESMO Faculty
/about-esmo/organisational-str...Subdomain ESMO Open Editorial Board
/about-esmo/organisational-str...Subdomain Guidelines Committee
/about-esmo/organisational-str...Subdomain ESMO-Magnitude of Clinical Benefit Scale Working Group
/about-esmo/organisational-str...Subdomain Major Achievements
/about-esmo/organisational-str...Subdomain IOTECH Editorial Board
/about-esmo/organisational-str...Subdomain Leadership Development Committee
/about-esmo/organisational-str...Subdomain Membership Committee
/about-esmo/organisational-str...Subdomain National Societies Committee
/about-esmo/organisational-str...Subdomain Nomination Committee
/about-esmo/organisational-str...Subdomain Communication Committee
/about-esmo/organisational-str...Subdomain Women for Oncology Committee
/about-esmo/organisational-str...Subdomain Young Oncologists Committee
/about-esmo/organisational-str...Subdomain Text duplicate Major Achievements
/about-esmo/organisational-str...Subdomain ESMO Members: Get Involved
/about-esmo/organisational-str...Subdomain ESMO Committees: Application Form
/about-esmo/organisational-str...Subdomain Editor-in-Chief Of ESMO Rare Cancers
/about-esmo/organisational-str...Subdomain OPWG Open Call for Members
/about-esmo/organisational-str...Subdomain ESMO Task Forces
/about-esmo/organisational-str...Subdomain ESMO Gender Medicine Task Force
/about-esmo/organisational-str...Subdomain Climate Change Task Force
/about-esmo/organisational-str...Subdomain Resilience Task Force
/about-esmo/organisational-str...Subdomain ESMO Clinical Research Observatory Task Force (ECRO)
/about-esmo/how-we-workSubdomain Text duplicate How we work
/about-esmo/how-we-work/declar...Subdomain Declaration of Interest
/about-esmo/how-we-work/declar...Subdomain EFPIA Disclosure Code
/about-esmo/how-we-work/esmo-e...Subdomain ESMO Presidential Election: 2027-2028
/about-esmo/how-we-work/esmo-e...Subdomain ESMO Elections FAQ
/about-esmo/how-we-work/esmo-s...Subdomain ESMO Structure
/about-esmo/how-we-work/code-o...Subdomain Code of Conduct
/about-esmo/how-we-work/esmo-a...Subdomain ESMO Annual Report
/about-esmo/how-we-work/esmo-f...Subdomain ESMO Funding
/about-esmo/how-we-work/esmo-f...Subdomain 2022 Funding Sources
/about-esmo/how-we-work/esmo-f...Subdomain 2019 Funding Sources
/about-esmo/how-we-work/esmo-f...Subdomain 2020 Funding Sources
/about-esmo/how-we-work/esmo-f...Subdomain 2021 Funding Sources
/about-esmo/how-we-work/bylawsSubdomain ESMO Bylaws
/about-esmo/how-we-work/esmo-g...Subdomain General Assembly
/about-esmo/how-we-work/esmo-g...Subdomain Notification of 2023 ESMO General Assembly Vote
/about-esmo/biographiesSubdomain Biographies
/about-esmo/careers-at-esmoSubdomain Careers at ESMO
/about-esmo/discover-esmo-jour...Subdomain Discover ESMO Journals
/about-esmo/discover-esmo-jour...Subdomain Annals of Oncology
/about-esmo/discover-esmo-jour...Subdomain About Annals of Oncology
/about-esmo/discover-esmo-jour...Subdomain ESMO Open
/about-esmo/discover-esmo-jour...Subdomain Frequently Asked Questions
/about-esmo/discover-esmo-jour...Subdomain Immuno-Oncology and Technology
/about-esmo/discover-esmo-jour...Subdomain ESMO Gastrointestinal Oncology
/about-esmo/discover-esmo-jour...Subdomain ESMO Real World Data and Digital Oncology
/about-esmo/discover-esmo-jour...Subdomain ESMO Affiliated Journals
/about-esmo/discover-esmo-jour...Subdomain Cancer Treatment Reviews
/about-esmo/discover-esmo-jour...Subdomain Clinical Lymphoma Myeloma and Leukemia
/about-esmo/discover-esmo-jour...Subdomain Lung Cancer
/about-esmo/discover-esmo-jour...Subdomain The Breast
/about-esmo/discover-esmo-jour...Subdomain COVID-19 and cancer care in the ESMO journals
/about-esmo/esmo-brandSubdomain ESMO Brand
/about-esmo/esmo-brand/esmo-logoSubdomain ESMO Logo
/about-esmo/collaborate-with-esmoSubdomain Collaborate with ESMO
/about-esmo/collaborate-with-e...Subdomain Text duplicate Frequently Asked Questions
/about-esmo/president-letterSubdomain President Letter
/about-esmo/president-letter/s...Subdomain Stepping into the shoes of a Society with a global footprint
/about-esmo/president-letter/e...Subdomain Embracing a year of strong collaboration and steady progress
/about-esmo/joining-forcesSubdomain Joining Forces
/about-esmo/joining-forces/esm...Subdomain ESMO for World Cancer Day 2024
/about-esmo/joining-forces/esm...Subdomain ESMO for World Cancer Day 2023
/about-esmo/joining-forces/esm...Subdomain ESMO for World Cancer Day 2022
/about-esmo/joining-forces/esm...Subdomain ESMO for World Cancer Day 2021
/about-esmo/joining-forces/esm...Subdomain ESMO for World Cancer Day 2020
/about-esmo/contact-usSubdomain Contact Us
https://www.esmo.org/membershipSubdomain Membership
A-TITLE Membership
/membership/join-esmoSubdomain Join ESMO
/membership/member-benefitsSubdomain Member Benefits
/membership/membership-categor...Subdomain Membership Categories & Annual Fees
/membership/esmo-in-your-countrySubdomain ESMO in Your Country
https://www.esmo.org/guidelinesSubdomain Guidelines
A-TITLE Guidelines
/guidelines/guidelines-by-topicSubdomain Guidelines by topic
/guidelines/guidelines-by-topi...Subdomain Breast Cancer
/guidelines/guidelines-by-topi...Subdomain Cancers of Unknown Primary Site
/guidelines/guidelines-by-topi...Subdomain Endocrine and Neuroendocrine Cancers
/guidelines/guidelines-by-topi...Subdomain Gastrointestinal Cancers
/guidelines/guidelines-by-topi...Subdomain Genitourinary Cancers
/guidelines/guidelines-by-topi...Subdomain Gynaecological Cancers
/guidelines/guidelines-by-topi...Subdomain Haematological Malignancies
/guidelines/guidelines-by-topi...Subdomain Head and Neck Cancers
/guidelines/guidelines-by-topi...Subdomain Hereditary Syndromes
/guidelines/guidelines-by-topi...Subdomain Lung and Chest Tumours
/guidelines/guidelines-by-topi...Subdomain Melanoma and Skin Cancers
/guidelines/guidelines-by-topi...Subdomain Neuro-Oncology
/guidelines/guidelines-by-topi...Subdomain Sarcoma and GIST
/guidelines/guidelines-by-topi...Subdomain Supportive and Palliative Care
/guidelines/guidelines-newsSubdomain Guidelines News
/guidelines/esmo-expert-consen...Subdomain ESMO Expert Consensus Statements
/guidelines/pagaSubdomain Pan-Asian Guidelines Adaptation (PAGA)
/guidelines/esmo-guidelines-me...Subdomain ESMO Guidelines Methodology
/guidelines/pocket-guidelines-...Subdomain Pocket Guidelines & Mobile App
/guidelines/pocket-guidelines-...Subdomain Translated ESMO Pocket Guidelines
/guidelines/guidelines-slide-setsSubdomain Guidelines Slide Sets
/guidelines/cancer-patient-man...Subdomain Cancer Patient Management During the COVID-19 Pandemic
/guidelines/cancer-patient-man...Subdomain Disclaimer
/guidelines/cancer-patient-man...Subdomain Primary brain tumours in the COVID-19 era
/guidelines/cancer-patient-man...Subdomain Gastrointestinal cancers: Hepatocellular carcinoma (HCC) in the COVID-19 era
/guidelines/cancer-patient-man...Subdomain Genitourinary cancers: Urothelial cancer of the bladder in the COVID-19 era
/guidelines/cancer-patient-man...Subdomain Genitourinary cancers: Renal cell cancer in the COVID-19 era
/guidelines/cancer-patient-man...Subdomain Genitourinary cancers: Prostate cancer in the COVID-19 era
/guidelines/cancer-patient-man...Subdomain Gynaecological malignancies: Cervical cancer in the COVID-19 era
/guidelines/cancer-patient-man...Subdomain Gynaecological malignancies: Endometrial cancer in the COVID-19 era
/guidelines/cancer-patient-man...Subdomain Haematological malignancies: DLBCL, MCL and Aggressive T-cell lymphoma in the second phase of the COVID-19 pandemic (ESMO-EHA)
/guidelines/cancer-patient-man...Subdomain Haematological malignancies: Hodgkin lymphoma in the second phase of the COVID-19 pandemic (ESMO-EHA)
/guidelines/cancer-patient-man...Subdomain Haematological malignancies: Indolent B-NHL in the second phase of the COVID-19 pandemic (ESMO-EHA)
/guidelines/cancer-patient-man...Subdomain Haematological malignancies: Multiple myeloma in the COVID-19 era
/guidelines/cancer-patient-man...Subdomain Head and neck cancers in the COVID-19 era
/guidelines/cancer-patient-man...Subdomain Melanoma in the COVID-19 era
/guidelines/cancer-patient-man...Subdomain Sarcomas in the COVID-19 era
/guidelines/cancer-patient-man...Subdomain Supportive Care in the COVID-19 era
/guidelines/covid-19-palliativ...Subdomain COVID-19 Palliative Care Pathways
/guidelines/q-a-on-covid-19Subdomain Q&A on COVID-19
/guidelines/covid-19-adapted-r...Subdomain COVID-19 adapted recommendations Slide Sets
/guidelines/esmo-mcbsSubdomain ESMO-MCBS
/guidelines/esmo-mcbs/esmo-mcb...Subdomain ESMO-MCBS in Action
/guidelines/esmo-mcbs/esmo-mcb...Subdomain ESMO-MCBS sessions at ESMO 2020
/guidelines/esmo-mcbs/esmo-mcb...Subdomain ESMO-MCBS Online Tutorials
/guidelines/esmo-mcbs/about-th...Subdomain About the ESMO-MCBS
/guidelines/esmo-mcbs/esmo-mcb...Subdomain ESMO-MCBS Terms of Use
/guidelines/esmo-mcbs/esmo-mcb...Subdomain ESMO-MCBS for Haematological Malignancies
/guidelines/esmo-mcbs/esmo-mcb...Subdomain ESMO-MCBS for Solid Tumours
/about-esmo-meetingsSubdomain Meetings
A-TITLE Meetings
/meeting-calendarSubdomain Text duplicate Meeting Calendar
/meeting-calendar/past-meetingsSubdomain Past Meetings
/about-esmo-meetings/esmo-cong...Subdomain ESMO Congresses
/about-esmo-meetings/esmo-virt...Subdomain ESMO Virtual Plenaries
/about-esmo-meetings/esmo-virt...Subdomain Sponsors
/about-esmo-meetings/esmo-virt...Subdomain Abstracts
/about-esmo-meetings/esmo-virt...Subdomain FAQs
/about-esmo-meetings/esmo-academySubdomain ESMO Academy
/about-esmo-meetings/esmo-adva...Subdomain ESMO Advanced Courses
/about-esmo-meetings/esmo-adva...Subdomain Text duplicate FAQs
/about-esmo-meetings/esmo-adva...Subdomain Acknowledgements
/about-esmo-meetings/esmo-adva...Subdomain Testimonials
/about-esmo-meetings/esmo-prec...Subdomain ESMO Preceptorship Courses
/about-esmo-meetings/esmo-prec...Subdomain Text duplicate Acknowledgements
/about-esmo-meetings/esmo-prec...Subdomain Text duplicate FAQs
/about-esmo-meetings/esmo-prec...Subdomain Text duplicate Testimonials
/about-esmo-meetings/esmo-summitsSubdomain ESMO Summits
/about-esmo-meetings/esmo-summ...Subdomain Text duplicate Testimonials
/about-esmo-meetings/esmo-cour...Subdomain ESMO Courses in Medical Oncology for Medical Students
/about-esmo-meetings/esmo-cour...Subdomain ESMO Best Student Award
/about-esmo-meetings/esmo-cour...Subdomain Text duplicate Testimonials
/about-esmo-meetings/eso-esmo-...Subdomain ESO-ESMO Masterclasses
/about-esmo-meetings/esmo-symp...Subdomain ESMO Symposia
/about-esmo-meetings/esmo-coll...Subdomain ESMO Colloquia
/about-esmo-meetings/esmo-webi...Subdomain ESMO Webinar Series
/about-esmo-meetings/workshops...Subdomain Workshops
/about-esmo-meetings/esmo-even...Subdomain ESMO Events App
/about-esmo-meetings/esmo-even...Subdomain How to Use the App
/about-esmo-meetings/esmo-lice...Subdomain ESMO Licensed Events
/career-developmentSubdomain Career Development
A-TITLE Career development
/career-development/oncology-f...Subdomain Oncology Fellowships
/career-development/oncology-f...Subdomain Host Institutes
/career-development/oncology-f...Subdomain Host an ESMO Fellow
/career-development/oncology-f...Subdomain Fellowship Offers
/career-development/oncology-f...Subdomain Benefits for Institutes
/career-development/oncology-f...Subdomain Awardees and Reports
/career-development/oncology-f...Subdomain External Oncology Fellowship Opportunities
/career-development/oncology-f...Subdomain About Oncology Fellowships
/career-development/resilience...Subdomain Text duplicate Resilience Task Force
/career-development/resilience...Subdomain ESMO Resilience Task Force: Survey Series
/career-development/young-onco...Subdomain Young Oncologists Corner
/career-development/young-onco...Subdomain Young Oncologists Track
/career-development/young-onco...Subdomain YO4YO Virtual Session Series
/career-development/young-onco...Subdomain About Young Oncologists Corner
/career-development/young-onco...Subdomain National Activities
/career-development/young-onco...Subdomain Considering a Career Abroad?
/career-development/esmo-exami...Subdomain ESMO Examination
/career-development/esmo-exami...Subdomain Parallel Sessions
/career-development/esmo-exami...Subdomain Why Sit the ESMO Exam?
/career-development/esmo-exami...Subdomain ESMO Exam Talent Pool
/career-development/esmo-exami...Subdomain Sample Exam Questions Explained
/career-development/esmo-exami...Subdomain Best Exam Award
/career-development/recertific...Subdomain Recertification & CME
/career-development/recertific...Subdomain ESMO-MORA Recertification Process and Requirements
/career-development/recertific...Subdomain CME Tests for Handbooks
/career-development/esmo-certi...Subdomain ESMO Certificate of Professional Development
/career-development/esmo-certi...Subdomain Text duplicate ESMO Advanced Courses
/career-development/esmo-certi...Subdomain Text duplicate ESMO Preceptorship Courses
/career-development/esmo-certi...Subdomain Text duplicate ESMO Webinar Series
/career-development/esmo-certi...Subdomain Text duplicate ESMO Virtual Plenaries
/career-development/jobs-in-on...Subdomain Jobs in Oncology
/career-development/women-for-...Subdomain Women for Oncology
/career-development/women-for-...Subdomain ESMO W4O Observatory
/career-development/women-for-...Subdomain W4O Hub
/career-development/women-for-...Subdomain Resource Centre
/career-development/women-for-...Subdomain W4O Sessions and Events
/career-development/leaders-ge...Subdomain Leaders Generation Programme
/career-development/leaders-ge...Subdomain Class of 2021-2022
/career-development/leaders-ge...Subdomain Class of 2016
/career-development/leaders-ge...Subdomain Class of 2017
/career-development/leaders-ge...Subdomain Class of 2018
/career-development/leaders-ge...Subdomain Class of 2019
/career-development/leaders-ge...Subdomain Leaders Generation Programme Asia
/career-development/leaders-ge...Subdomain Text duplicate Class of 2019
/career-development/leaders-ge...Subdomain Class of 2022
/career-development/travel-gra...Subdomain Travel Grants for ESMO Meetings
/career-development/about-care...Subdomain About Career Development
/scales-and-toolsSubdomain Scales and Tools
A-TITLE Scales and Tools
/scales-and-tools/esmo-guidanc...Subdomain ESMO Guidance for Reporting Oncology real-World Evidence (ESMO-GROW)
/scales-and-tools/esmo-scale-f...Subdomain ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)
/scales-and-tools/esmo-mcbsSubdomain Text duplicate ESMO-MCBS
https://www.esmo.org/researchSubdomain Research
A-TITLE Research
/research/about-the-grant-schemesSubdomain About the Grant Schemes
/research/esmo-clinical-resear...Subdomain Text duplicate ESMO Clinical Research Observatory Task Force (ECRO)
/research/esmo-clinical-resear...Subdomain Acknowledgements: Rationalizing Bureaucracy
/research/esmo-clinical-resear...Subdomain Bibliography on Clinical Trial Procedures
/research/research-funding-opp...Subdomain Research Funding opportunities
/research/research-funding-opp...Subdomain ESMO Webinar: EU Research Opportunities
/research/research-funding-opp...Subdomain How to Apply For EU Grants
/research/research-funding-opp...Subdomain EU Calls for Proposals
/research/research-funding-opp...Subdomain Training and Events
/research/research-funding-opp...Subdomain Regulatory Information
/research/research-funding-opp...Subdomain Other Research Funding Opportunities
/research/research-groups-tool...Subdomain Research Groups, Tools and Database
/research/research-groups-tool...Subdomain General research groups
/research/research-groups-tool...Subdomain Cancer research groups by type
/research/research-groups-tool...Subdomain Databases
/research/research-groups-tool...Subdomain Research tools
/research/registries-studies-a...Subdomain COVID-19 and Cancer: Registries, Studies and Surveys
/research/registries-studies-a...Subdomain ESMO-CoCARE Registry
https://www.esmo.org/for-patientsSubdomain For Patients
A-TITLE Patients
/for-patients/resources-for-ca...Subdomain Resources for Patients with Cancer
/for-patients/esmo-designated-...Subdomain ESMO Designated Centres of Integrated Oncology and Palliative Care
/for-patients/esmo-designated-...Subdomain Palliative and Supportive Care Sessions at ESMO Congress 2022 Paris
/for-patients/esmo-designated-...Subdomain How to re-accredit?
/for-patients/esmo-designated-...Subdomain Text duplicate Designated Centres Working Group
/for-patients/esmo-designated-...Subdomain Palliative and Supportive Care Sessions at ESMO Congress 2023 Madrid
/for-patients/esmo-designated-...Subdomain 2023 ESMO Designated Centres
/for-patients/cancer-care-duri...Subdomain Cancer Care During the COVID-19 Pandemic
/for-patients/cancer-care-duri...Subdomain Multiple Myeloma
/for-patients/cancer-care-duri...Subdomain Melanoma
/for-patients/cancer-care-duri...Subdomain Sarcoma
/for-patients/cancer-care-duri...Subdomain Krebstherapie während der COVID-19-Pandemie
/for-patients/cancer-care-duri...Subdomain Renal Cell Carcinoma
/for-patients/cancer-care-duri...Subdomain Prostate Cancer
/for-patients/cancer-care-duri...Subdomain Pancreatic Cancer
/for-patients/cancer-care-duri...Subdomain Text duplicate Lung Cancer
/for-patients/cancer-care-duri...Subdomain Ovarian Cancer
/for-patients/cancer-care-duri...Subdomain Palliative Care Glossary
/for-patients/cancer-care-duri...Subdomain Supportive Care Glossary
/for-patients/cancer-care-duri...Subdomain Gastro-Oesophageal Cancer
/for-patients/cancer-care-duri...Subdomain Hepatocellular Carcinoma
/for-patients/cancer-care-duri...Subdomain Endometrial Cancer
/for-patients/cancer-care-duri...Subdomain Colorectal Cancer
/for-patients/cancer-care-duri...Subdomain Primary Brain Tumour
/for-patients/cancer-care-duri...Subdomain Aggressive Lymphoma Management
/for-patients/cancer-care-duri...Subdomain Text duplicate Breast Cancer
/for-patients/cancer-care-duri...Subdomain B-cell non-Hodgkin Lymphoma
/for-patients/cancer-care-duri...Subdomain Urothelial Bladder Cancer
/for-patients/cancer-care-duri...Subdomain Hodgkin Lymphoma
/for-patients/cancer-care-duri...Subdomain Cervical Cancer
/for-patients/cancer-care-duri...Subdomain Traitement du Cancer au Cours de la Pandémie de COVID-19
/for-patients/cancer-care-duri...Subdomain Le Cure per il Cancro Durante la Pandemia da COVID-19
/for-patients/cancer-care-duri...Subdomain Cuidado del cáncer durante la pandemia de COVID-19
/for-patients/cancer-care-duri...Subdomain Glossary
/for-patients/patient-advocate...Subdomain Patient Advocates Working Group
/for-patients/patient-advocacy...Subdomain Patient Advocacy Track
/for-patients/patient-guidesSubdomain Patient Guides
/for-patients/patient-guides/p...Subdomain Patient Guides by Language
/for-patients/patient-guides/b...Subdomain Bone Health in Cancer
/for-patients/patient-guides/p...Subdomain Immunotherapy Side Effects
/for-patients/patient-guides/s...Subdomain Survivorship
/for-patients/patient-guides/c...Subdomain Cancer Pain Management
/for-patients/patient-guides/p...Subdomain Personalised Cancer Medicine
/for-patients/personalised-med...Subdomain Personalised Medicine Explained
/for-patients/getting-the-most...Subdomain Getting the Most out of Your Oncologist
/for-patients/esmo-patient-eng...Subdomain ESMO Patient Engagement Summit
https://www.esmo.org/policySubdomain Policy
A-TITLE Policy
/policy/esmo-manifestoSubdomain ESMO Manifesto
/policy/policy-newsSubdomain Policy News
/policy/esmo-public-policy-com...Subdomain Public Policy Committee
/policy/patient-advocates-work...Subdomain Text duplicate Patient Advocates Working Group
/policy/cancer-medicines-commi...Subdomain Text duplicate Cancer Medicines Committee
/policy/esmo-public-policy-tra...Subdomain ESMO Public Policy Track and Special Sessions
https://www.esmo.org/newsroomSubdomain Newsroom
A-TITLE Newsroom
/newsroom/press-and-media-hubSubdomain Press and Media Hub
https://dailyreporter.esmo.org/New window Nofollow External Subdomain ESMO Daily Reporter
/oncology-newsSubdomain Oncology News
A-TITLE Oncology News
/newsroom/esmo-society-updatesSubdomain ESMO Society Updates
/membership/join-esmoSubdomain Text duplicate Become a member
https://www.esmo.org/saml/loginText duplicate Login
/meeting-calendar/esmo-immuno-...Subdomain ESMO Immuno-Oncology Congress 2024
/meeting-calendar/esmo-immuno-...Subdomain Submit your abstract
/meeting-calendar/esmo-guideli...New window Subdomain IMG-ALT ESMO-Webinar-Series-Nasopharyngeal-Carcinoma-ESMO-EURACAN-1000x250-July
/meeting-calendar/esmo-guideli...Subdomain Nasopharyngeal Carcinoma Webinar
/meeting-calendar/esmo-guideli...Subdomain Register Now
/living-guidelines/esmo-oncoge...New window Subdomain IMG-ALT ESMO-Clinical-Practice-Guidelines-1000x250-Oncogene-Addicted-Metastatic-Non-Small-Cell-Lung-Cancer
/living-guidelines/esmo-oncoge...Subdomain ESMO Oncogene-Addicted mNSCLC Living Guideline
/living-guidelines/esmo-oncoge...Subdomain To the Guideline
/meeting-calendar/esmo-asia-co...Subdomain ESMO Asia 2024
/meeting-calendar/esmo-asia-co...Subdomain Sign up before 4 September
/meeting-calendar/molecular-an...Subdomain Molecular Analysis for Precision Oncology Congress 2024
/meeting-calendar/molecular-an...Subdomain Submit your abstract by 23 July!
/meeting-calendar/esmo-precept...New window Subdomain IMG-ALT ESMO-Preceptorship-Lung-Cancer-1000x1000
/meeting-calendar/esmo-precept...Subdomain ESMO Preceptorship on Lung Cancer, 15-16 November 2024, Paris, France
/meeting-calendar/esmo-precept...Subdomain Apply now!
/meeting-calendar/esmo-precept...New window Subdomain IMG-ALT ESMO-Preceptorship-Gastric-Cancer-1000x1000
/meeting-calendar/esmo-precept...Subdomain ESMO Preceptorship Course on Gastric Cancer, 4-5 December 2024, Singapore
/meeting-calendar/esmo-precept...Subdomain Text duplicate Apply now!
/guidelines/esmo-mcbsNew window Subdomain IMG-ALT ESMO-MCBS 1000x1000
/guidelines/esmo-mcbsSubdomain Text duplicate ESMO-MCBS
/guidelines/esmo-mcbsSubdomain Discover more
https://oncologypro.esmo.org/m...External Subdomain July ESMO Virtual Plenary
https://oncologypro.esmo.org/m...External Subdomain  Watch Now
/oncology-news/development-of-...Subdomain Development of T-Cell Lymphoma After Chimeric Antigen Receptor T-Cell Therapy
/oncology-news/ema-recommends-...Subdomain EMA Recommends Granting a Conditional Marketing Authorisation for Odronextamab
/oncology-news/entrectinib-is-...Subdomain Entrectinib Is Effective and Well Tolerated in Patients with Treatment-Naïve ROS1-positive Advanced/Metastatic NSCLC
/oncology-news/fda-approves-du...Subdomain FDA Approves Durvalumab with Chemotherapy for Mismatch Repair Deficient Primary Advanced or Recurrent Endometrial Cancer
https://dailyreporter.esmo.org...External Subdomain First-line avimantamab plus lazertinib shows efficacy in patients with high-risk EGFR-mutant advanced NSCLC
/oncology-news/one-year-of-adj...Subdomain One Year of Adjuvant T-DM1 Leads to Outstanding Long-Term Outcomes Among Patients with Stage I HER2-positive Breast Cancer
/for-patients/patient-guides/b...Subdomain Patient Guide in Bladder Cancer Now Available Also in Greek
/oncology-news/ema-recommends-...Subdomain EMA Recommends Extension of Therapeutic Indications for Olaparib to Patients with Endometrial Cancer
/oncology-news/pet-2-guided-br...Subdomain PET-2-Guided BrECADD Better Tolerated and More Effective than eBEACOPP in Patients with Newly Diagnosed, Advanced-Stage cHL
/oncology-newsSubdomain More Oncology News
/newsroom/press-and-media-hub/...Subdomain More Press Releases
/newsroom/esmo-society-updatesSubdomain More Society Updates
https://dailyreporter.esmo.org/New window External Subdomain Read the ESMO Daily Reporter
/oncology-news/development-of-...Subdomain Text duplicate Development of T-Cell Lymphoma After Chimeric Antigen Receptor T-Cell Therapy
/oncology-news/ema-recommends-...Subdomain Text duplicate EMA Recommends Granting a Conditional Marketing Authorisation for Odronextamab
/oncology-news/entrectinib-is-...Subdomain Text duplicate Entrectinib Is Effective and Well Tolerated in Patients with Treatment-Naïve ROS1-positive Advanced/Metastatic NSCLC
/oncology-news/fda-approves-du...Subdomain Text duplicate FDA Approves Durvalumab with Chemotherapy for Mismatch Repair Deficient Primary Advanced or Recurrent Endometrial Cancer
/oncology-news/one-year-of-adj...Subdomain Text duplicate One Year of Adjuvant T-DM1 Leads to Outstanding Long-Term Outcomes Among Patients with Stage I HER2-positive Breast Cancer
/oncology-news/ema-recommends-...Subdomain Text duplicate EMA Recommends Extension of Therapeutic Indications for Olaparib to Patients with Endometrial Cancer
/oncology-news/pet-2-guided-br...Subdomain Text duplicate PET-2-Guided BrECADD Better Tolerated and More Effective than eBEACOPP in Patients with Newly Diagnosed, Advanced-Stage cHL
/oncology-news/fda-grants-acce...Subdomain FDA Grants Accelerated Approval to Adagrasib with Cetuximab for KRAS G12C-mutated Advanced Colorectal Cancer
/oncology-news/second-or-third...Subdomain Second- or Third-Line Treatment with Tisotumab Vedotin Results in Greater Efficacy than Chemotherapy in Patients with Recurrent Cervical Cancer
/oncology-newsSubdomain Text duplicate More Oncology News
/newsroom/press-and-media-hub/...Subdomain Prevention and Early Detection of Gastrointestinal Cancers Take on New Importance Amidst a Younger Population
/newsroom/press-and-media-hub/...Subdomain Cross-Border Network of European Specialists Provides New Treatment Options For Women with Complex Rare Gynaecological Cancers
/newsroom/press-and-media-hub/...Subdomain ESMO Gastrointestinal Cancers Congress 2024 Munich, Germany, 26-29 June
/newsroom/press-and-media-hub/...Subdomain ESMO Gynaecological Cancers Congress 2024, 20-22 June, Florence, Italy
/newsroom/press-and-media-hub/...Subdomain World No Tobacco Day 2024: European Societies call for an EU Endgame on Tobacco
/newsroom/press-and-media-hub/...Subdomain Assisted Reproduction Treatments are Safe in Young Breast Cancer Survivors with High-risk Genes
/newsroom/press-and-media-hub/...Subdomain ESMO Breast Cancer 2024, 15-17 May, Berlin, Germany
/newsroom/press-and-media-hub/...Subdomain European Lung Cancer Congress 2024, 20-23 March, Prague, Czech Republic
/newsroom/press-and-media-hub/...Subdomain ESMO Sarcoma and Rare Cancers Congress 2024, 14-16 March, Lugano, Switzerland
/newsroom/press-and-media-hub/...Subdomain Text duplicate More Press Releases
/newsroom/esmo-society-updates...Subdomain ESMO Calls for Urgent Action at Both EU and National Levels to Safeguard the Future of Oncological Research in Europe
/newsroom/esmo-society-updates...Subdomain ESMO Journals Have Maintained Strong Impact Factors
/newsroom/esmo-society-updates...Subdomain New ESMO President 2027-2028 Elected
/newsroom/esmo-society-updates...Subdomain Three Prominent ESMO Officers Shine in News Pages for Their Accomplishments in Cancer Research
/newsroom/esmo-society-updates...Subdomain Medical Oncologists Incredulous at the Commission’s Latest Backtracking on the Evaluation of the EU Tobacco Products Directive
/newsroom/esmo-society-updates...Subdomain 2024 ESMO Breast Cancer Award Recipient Announced
/newsroom/esmo-society-updates...Subdomain 2024 Heine H. Hansen Award Recipient Announced
/newsroom/esmo-society-updates...Subdomain Nomination Process for the 2024 ESMO Society Awards Now Open 
/newsroom/esmo-society-updates...Subdomain ESMO Committees and Working Groups: New Chair Appointments
/newsroom/esmo-society-updatesSubdomain Text duplicate More Society Updates
https://dailyreporter.esmo.org...External Subdomain Text duplicate First-line avimantamab plus lazertinib shows efficacy in patients with high-risk EGFR-mutant advanced NSCLC
https://dailyreporter.esmo.org...External Subdomain Eftilagimod alpha plus pembrolizumab shows promise in HNSCC with negative PD-1 expression
https://dailyreporter.esmo.org...External Subdomain How to interpret genomic testing results? ESMO recommendations to make reports easy to read
https://dailyreporter.esmo.org...External Subdomain Oncologists do not feel well-prepared to address the health needs of LGBTQ cancer patients
https://dailyreporter.esmo.org...External Subdomain Doublet immunotherapy consolidates its role in hepatocellular carcinoma
https://dailyreporter.esmo.org...External Subdomain Ten years of improvement in the treatment of liver cancer
https://dailyreporter.esmo.org...External Subdomain Growing evidence supports the use of ctDNA as a biomarker in colon cancer
https://dailyreporter.esmo.org...External Subdomain Harnessing the power of the gut microbiome in colorectal cancer
https://dailyreporter.esmo.org...External Subdomain Liver transplantation plus chemotherapy prolongs survival in patients with definitively unresectable colorectal liver metastases
https://dailyreporter.esmo.org/New window External Subdomain Text duplicate Read the ESMO Daily Reporter
https://www.esmo.org/guidelinesNew window Subdomain IMG-ALT Provide your patients with the best care options.
https://www.esmo.org/guidelinesSubdomain Text duplicate Provide your patients with the best care options.
https://www.esmo.org/guidelinesSubdomain Read the guidelines
/about-esmo-meetings/esmo-prec...Subdomain Preceptorships
/about-esmo-meetings/esmo-cour...Subdomain Courses on Medical Oncology for Medical Students
/about-esmo-meetings/esmo-adva...Subdomain Advanced Courses
/about-esmo-meetings/esmo-summitsSubdomain Summits
/about-esmo/discover-esmo-jour...New window Subdomain IMG-ALT ESMO Oncology Journals
/about-esmo/discover-esmo-jour...Subdomain Text duplicate ESMO Oncology Journals
/about-esmo/discover-esmo-jour...Subdomain Text duplicate Annals of Oncology
/about-esmo/discover-esmo-jour...Subdomain Text duplicate ESMO Open
/about-esmo/discover-esmo-jour...Subdomain ESMO IO Tech
/about-esmo/discover-esmo-jour...Subdomain More about Journals
https://oncologypro.esmo.org/e...New window External Subdomain IMG-ALT Publications
https://oncologypro.esmo.org/e...External Subdomain Text duplicate Publications
https://oncologypro.esmo.org/e...New window External Subdomain Essentials for Clinicians
https://oncologypro.esmo.org/e...New window External Subdomain Handbooks
https://oncologypro.esmo.org/e...New window External Subdomain Factsheet on Biomarkers
https://oncologypro.esmo.org/e...New window External Subdomain Visit the Education library
/meeting-calendar/esmo-course-...Subdomain IMG-ALT ESMO-Medical-Student-Course-Valencia-2024-1000x1000
/meeting-calendar/esmo-course-...Subdomain ESMO Course in Medical Oncology for Medical Students Valencia 2024
/meeting-calendar/esmo-precept...Subdomain IMG-ALT ESMO-Preceptorship-Breast-Cancer-1000x1000
/meeting-calendar/esmo-precept...Subdomain ESMO Preceptorship on Breast Cancer 2024: Munich
/meeting-calendar/esmo-academy...Subdomain IMG-ALT ESMO-Academy-Meeting-2024-1000x1000
/meeting-calendar/esmo-academy...Subdomain ESMO Academy 2024
/meeting-calendar/esmo-course-...Subdomain IMG-ALT ESMO-Medical-Student-Course-Naples-2024-1000x1000
/meeting-calendar/esmo-course-...Subdomain ESMO Course in Medical Oncology for Medical Students Naples 2024
/meeting-calendar/esmo-advance...Subdomain IMG-ALT ESMO-Advanced-Courses-Breast-Cancer-1000x1000
/meeting-calendar/esmo-advance...Subdomain ESMO Advanced Course on Role of CDK4/6 Inhibitors in Hormone Receptor Positive HER2 Negative in Breast Cancer 2024: Jeddah
/meeting-calendar/esmo-congres...Subdomain IMG-ALT ESMO-Congress-2024-1000x1000
/meeting-calendar/esmo-congres...Subdomain ESMO Congress 2024
/meeting-calendar/esmo-precept...Subdomain IMG-ALT ESMO-Preceptorship-Ovarian-Cancer-2024-1000x1000
/meeting-calendar/esmo-precept...Subdomain ESMO Preceptorship on Ovarian Cancer 2024: Lisbon
/meeting-calendar/esmo-precept...Subdomain Text duplicate IMG-ALT ESMO-Preceptorship-Gastric-Cancer-1000x1000
/meeting-calendar/esmo-precept...Subdomain ESMO Preceptorship on Gastric Cancer 2024: Lisbon
/meeting-calendar/esmo-precept...Subdomain IMG-ALT ESMO-Preceptorship-Molecular Cancer Biology-1000x1000
/meeting-calendar/esmo-precept...Subdomain ESMO Preceptorship on Practising Oncology: Dealing with Special Strategies, Patient Populations and Toxicities 2024: Lugano
/meeting-calendar/esmo-advance...Subdomain IMG-ALT ESMO-Advanced-Courses-ADC-1000x1000
/meeting-calendar/esmo-advance...Subdomain ESMO Advanced Course on ADC Development, Therapeutic Applications and Research: Breast, Gynaecological and GI Cancers 2024: Zurich
/meeting-calendar/esmo-advance...Subdomain Text duplicate IMG-ALT ESMO-Advanced-Courses-ADC-1000x1000
/meeting-calendar/esmo-advance...Subdomain ESMO Advanced Course on ADC Development, Therapeutic Applications and Research: Thoracic and GU Cancers 2024: Singapore
/meeting-calendar/esmo-advance...Subdomain Text duplicate IMG-ALT ESMO-Advanced-Courses-ADC-1000x1000
/meeting-calendar/esmo-advance...Subdomain ESMO Advanced Course on ADC Development, Therapeutic Applications and Research: Breast, Gynaecological and GI Cancers 2024: Singapore
/meeting-calendarSubdomain Discover all ESMO meetings
https://www.youtube.com/user/E...External Subdomain Watch all ESMO videos
/career-development/oncology-f...Subdomain Are you looking for a fellowship not offered by ESMO or would like to post a fellowship?
/career-development/oncology-f...Subdomain External Fellowship
/career-development/esmo-exami...Subdomain Text duplicate ESMO Examination
/career-development/esmo-exami...Subdomain Trivial anchor text
Read more
/career-development/oncology-f...Subdomain Thinking of applying for an ESMO Oncology Fellowship?
/career-development/oncology-f...Subdomain Fellowship Programme
/membership/member-benefitsSubdomain Discover member benefits
https://www.esmo.org/terms-of-useSubdomain Terms of Use
/terms-of-use/privacy-policySubdomain Privacy Policy
https://www.esmo.org/about-esmoSubdomain Text duplicate About ESMO
/about-esmo/contact-usSubdomain Text duplicate Contact Us
https://esmo.my.site.com/myesm...External Subdomain Login to your ESMO account
https://www.twitter.com/myesmoNew window External Subdomain Twitter
https://www.facebook.com/esmo.orgNew window External Subdomain Facebook
https://www.youtube.com/user/E...New window External Subdomain Youtube
/rss/feed/esmo-newsSubdomain RSS
https://www.linkedin.com/compa...New window External Subdomain LinkedIn
https://www.instagram.com/esmo...New window External Subdomain Instagram
https://www.esmo.org/Anchor No Text
/terms-of-use/privacy-policyNew window Subdomain Text duplicate Privacy Policy

Server configuration

HTTP redirects
(Critically important)
This page redirects to "https://www.esmo.org/"
HTTP header
(Important)
No X-Powered HTTP header is sent.
This page uses GZip for compressed data transmission.
Performance
(Somewhat important)
The page response time is excellent with 0.10 seconds.
The file size of the HTML document is fine (340 kB).

HTTP Response Header

NameValue
content-typetext/html; charset=UTF-8
dateMon, 22 Jul 2024 08:56:20 GMT
content-encodinggzip
x-varnish316704387 314342048
age164
varyAccept-Encoding
cache-controlprivate, no-cache, no-store, must-revalidate
accept-rangesbytes
strict-transport-securitymax-age=16000000; preload;
statuscode200
http_versionHTTP/2

External factors

Blacklists
(Nice to have)
This website is not classified "for adult only".
This page is referenced by wikipedia.
This website has excellent links from other websites.
This page has backlinks from 5,683 referring domains.
This page has 902,116 backlinks.
This page has backlinks from 4,083 different ip addresses.
Facebook popularity
(Somewhat important)
The page has 0 shares and comments on Facebook.

Links from Wikipedia

You can find more links using Wikipedia search

Robots.txt

User-agent: *
Crawl-delay: 5
Disallow: /content/search
Disallow: /search
Disallow: /user/login
Disallow: /user/logout
Disallow: /login
Disallow: /logout
Disallow: /saml/
Disallow: /layout/
Disallow: /nglayouts/ajax/
Disallow: /myesmo/
Disallow: /Function/
Disallow: /Event-Type/
Disallow: /Term/
Disallow: /Promoted-content/
Disallow: /view-news/
Disallow: /resources/
Disallow: /useful-links/
Disallow: /no_cache/
Disallow: /fileadmin/
Disallow: /events/
Disallow: /education-research/
Disallow: /career-grants/
Disallow: /Helpdesk-Categories
Disallow: /ESMO-Members-Forum
Disallow: /Featured-articles
Disallow: /Links
Disallow: /Tests
Disallow: /_deprecated/
Disallow: /_tagging-objects/
Disallow: /_old-structure/
Disallow: /daily_reporter/
Disallow: /living-guidelines/
Disallow: /esp/
Disallow: /attendances/certificate/
Sitemap: https://www.esmo.org/sitemaps/index

User-agent: MJ12bot
Disallow: /

User-agent: AhrefsBot
Disallow: /

Similar sites

Search preview

www.esmo.org
European Society for Medical Oncology
ESMO is Europe’s leading medical oncology society, providing a professional network for its members and working with national societies across Europe.

Most important keywords

Following keywords were found. You can check the keyword optimization of this page for each keyword.

KeywordResultRecheck
Oncology81%Check
Medical81%Check
Medical Oncology81%Check
Society Medical79%Check
Society77%Check
Europe77%Check
European Society72%Check
ESMO Oncology67%Check
European66%Check
ESMO Society65%Check
Show more keywords and terms

Test up to 1.000 webpages of esmo.org with our free plan!

Try For Free
No trial. It's just free!

Cookie Policy

We use cookies to make our site work and also for analytics and advertising purposes. You can enable or disable optional cookies as desired. See the following links for more information.

Contact | Privacy

We need these so the site can function properly

So we can better understand how visitors use our website

So we can serve you tailored ads and promotions